Innoviva to Participate in the Cantor Global Healthcare Conference
19 9월 2023 - 9:30PM
Business Wire
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified
holding company with a portfolio of royalties and other healthcare
assets, today announced that Pavel Raifeld, Chief Executive
Officer, will participate in a fireside chat at the Cantor Global
Healthcare Conference in New York, NY on Wednesday, September 27,
2023 at 1:50 p.m. Eastern Time.
A live webcast of the fireside chat can be accessed under
“Events & Presentations” in the Investor Relations section of
the Company’s website at
https://investor.inva.com/presentations-events. The webcast will be
available for replay for 90 days following the event.
About Innoviva
Innoviva, Inc., is a diversified holding company with a
portfolio of royalties and other healthcare assets, including
Innoviva Specialty Therapeutics, a subsidiary focused on delivering
innovative therapies in critical care and infectious disease.
Innoviva’s royalty portfolio includes respiratory assets partnered
with Glaxo Group Limited (GSK), including RELVAR®/BREO® ELLIPTA®
(fluticasone furoate/vilanterol, FF/VI) and ANORO® ELLIPTA®
(umeclidinium bromide/vilanterol, UMEC/VI). Under the Long-Acting
Beta2 Agonist (LABA) Collaboration Agreement, Innoviva is entitled
to receive royalties from GSK on sales of RELVAR®/BREO® ELLIPTA®
and ANORO® ELLIPTA®. ANORO®, RELVAR® and BREO® are trademarks of
the GSK group of companies. For more information on Innoviva,
please visit here.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230919112391/en/
Investors & Media: Argot Partners (212) 600-1902
innoviva@argotpartners.com
Innoviva (NASDAQ:INVA)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Innoviva (NASDAQ:INVA)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024